IPO8抗体;IPO8 Antibody—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human gasrtic cancer tissue using P11858(IPO8 Antibody) at dilution 1/50. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P11858(IPO8 Antibody) at dilution 1/50. (Original magnification: ×200)    

  
  

IPO8 (Importin-8) is a member of the importin-β family of nuclear transport receptors, which mediate nucleocytoplasmic trafficking of proteins and RNA molecules. Unlike classical importins, IPO8 functions independently of importin-α adapters, directly recognizing cargoes via specific nuclear localization signals (NLS). It plays a critical role in transporting ribosomal proteins, transcription factors, and other macromolecular complexes into the nucleus. Studies suggest IPO8 is involved in diverse cellular processes, including ribosome biogenesis, gene expression regulation, and viral replication, by ensuring proper localization of key regulatory factors.

The IPO8 antibody is a valuable tool for detecting endogenous IPO8 protein in applications such as Western blotting, immunofluorescence, and immunoprecipitation. Its specificity allows researchers to investigate IPO8 expression levels, subcellular localization, and interactions under physiological or pathological conditions. Recent research highlights IPO8's potential relevance in cancer, as dysregulated nuclear transport mechanisms are linked to tumor progression and drug resistance. Additionally, IPO8 has been implicated in antiviral responses, where it may influence host-pathogen interactions by mediating nuclear import of viral components.

Commercial IPO8 antibodies are typically raised against conserved epitopes, validated for cross-reactivity in human, mouse, and rat models. Proper controls, such as siRNA knockdowns, are recommended to confirm antibody specificity in experimental settings.